Medical Legal Gilead Emerges Victorious in PrEP Lawsuits Thomas Sullivan May 11, 2023 0 Gilead Sciences recently was on the receiving end of two final judgments to the tune of $175.2 million. The judgments follow…
Pharmaceutical and Device Amgen Facing Lawsuit Over $10.7 Billion in IRS Taxes and Penalties Thomas Sullivan May 10, 2023 0 A Detroit-based pension fund filed a proposed class action lawsuit against Amgen, as well as Amgen CEO Robert Bradway and Chief…
DEA ATA Action Argues for Remote Prescribing of Controlled Substances Thomas Sullivan May 9, 2023 0 ATA Action, the affiliated trade organization for the American Telemedicine Association (ATA), the only organization “completely…
Anti Kickback Covenant Healthcare Reaches $69 Million Settlement for Violations of Stark… Thomas Sullivan May 8, 2023 0 Covenant Healthcare System, along with two of its physicians, recently reached agreements with the Department of Justice (DOJ) to…
DOJ LabCorp Reaches $2.1 Million Settlement to Resolve False Claims Act… Thomas Sullivan May 5, 2023 0 The United States Department of Justice (DOJ) announced that Laboratory Corporation of America (LabCorp) will pay $2.1 million to…
CMS Genotox Enters Into Settlement Agreement, As Well As CIA and DPA Over False… Thomas Sullivan May 4, 2023 0 Recently, Genotox Laboratories Ltd. agreed to pay at least $5.9 million to resolve False Claims Act allegations that the company…
CMS CMMI Plans to Release New Payment Models in 2023 Thomas Sullivan May 3, 2023 0 During the Value-Based Payment Summit, Center for Medicare and Medicaid Innovation (CMMI) Director Liz Fowler, Ph.D., outlined the…
Medicare Part D Changes Included in the Inflation Reduction Act May be Helpful, But… Thomas Sullivan May 2, 2023 0 The Inflation Reduction Act (IRA) passed in 2022 included several changes to the Medicare Part D benefits, aimed at improving…
CMS Program Safeguards Would Have Saved Medicare Money on Drug Testing Services… Thomas Sullivan May 1, 2023 0 From 2016 through 2020, Medicare Part B paid roughly $3 billion for 17.1 million definitive drug testing services to 3.3 million…
COVID-19 PhRMA Submits Comments to USITC Regarding Section 332 Investigation Thomas Sullivan Apr 28, 2023 0 The United States International Trade Commission (USITC) is investigating the impact of expanding the waiver of intellectual…